Mass spectrometry and immunoassay: How to measure steroid hormones today and tomorrow

European Journal of Endocrinology

Volumn 173, Issue 2, 2015, Pages D1-D12

  Taylor, Angela E ^a   Keevil, Brian ^b   Huhtaniemi, Ilpo T ^c,d  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HYDROCORTISONE; STEROID HORMONE; TESTOSTERONE; VITAMIN; HORMONE; STEROID;

ANTIBODY SPECIFICITY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STEROID ANALYSIS; STEROID METABOLISM; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; ANIMAL; PROCEDURES; TRENDS;

ANIMALS; CHROMATOGRAPHY, LIQUID; HORMONES; HUMANS; IMMUNOASSAY; MASS SPECTROMETRY; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 84938828730     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0338     Document Type: Review

References (72)

1. Schoenheimer R & Rittenberg D. Deuterium as an indicator in the study of intermediary metabolism. Science 1935 82 156-157. (doi:10.1126/science.82.2120.156)
2. Eneroth P, Hellström K &Ryhage R.Identification and quantification of neutral fecal steroids by gas-liquid chromatography and mass spectrometry: studies of human excretion during two dietary regimens. Journal of Lipid Research 1964 5 245-262.
3. Rhyage R. Use of a mass spectrometer as a detector and analyzer for effluent emerging from high temperature gas liquid chromatography columns. Analytical Chemistry 1964 36 759-764. (doi:10.1021/ac60210a019)
4. Shackelton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. Journal of Steroid Biochemistry and Molecular Biology 2010 121 481-490. (doi:10.1016/j.jsbmb.2010.02.017)
5. Krone N, Hughes BA, Lavery G, Stewart PM, Arlt W & Shackelton CH. Gas chromatography/mass spectrometry (GC/MS) remains a preeminent discovery tool in clinical chemistry investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). Journal of Steroid Biochemistry and Molecular Biology 2010 121 196-504. (doi:10.1016/j.jsbmb.2010.04.010)
6. Christakoudi S, Cowan DA & Taylor NF. Steroids excreted in urine by neonates with 21-hydroxylase deficiency: characterization, using GC-MS and GC-MS/MS, of the D-ring and side chain structure of pregnanes and pregnenes. Steroids 2010 75 34-52. (doi:10.1016/j.steroids.2009.09.011)
7. Zavada M, Safarcik K & Topolcan O. Some problems of radio immunoassay control. Journal of Radioanalytical Chemistry 1978 4657-66. (doi:10.1007/BF02519728)
8. Handelsman DJ & Wartofsky L. Requirement for mass spectrometry sex steroid assays in the journal of clinical endocrinology and metabolism. Journal of Clinical Endocrinology and Metabolism 2013 98 3971-3973. (doi:10.1210/jc.2013-3375)
9. Monaghan PJ, Keevil BG, Stewart PM & Trainer PJ. Case for the wider adoption of mass spectrometry-based steroid testing, and beyond. Journal of Clinical Endocrinology and Metabolism 2014 99 4434-4437. (doi:10.1210/jc.2014-2258)
10. Weirman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM & Stanczyk FZ. Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Journal of Clinical Endocrinology and Metabolism 2014 99 4375. (doi:10.1210/jc.2014-3424)
11. Botelho JC, Shacklady C, Cooper HC, Tai SS, Van Uytanghe K, Theinport LM & Vesper HW. Isotope-dilution liquid chromatography- tandem mass spectrometry candidate reference method for total testosterone in human serum. Clinical Chemistry 2013 59 372-380. (doi:10.1373/clinchem.2012.190934)
12. Hoofnagle AN & Wener MH. The fundamental flaws of immunoassay and potential solutions using tandem mass spectrometry. Journal of Immunological Methods 2009 347 3-11. (doi:10.1016/j.jim.2009.06.003)
13. Shackleton CH & Snodgrass GH. Steroid excretion by an infant with an unusual salt-losing syndrome: a gas chromatographic-mass spectrometric study. Annals of Clinical Biochemistry 1974 11 91-99. (doi:10.1177/000456327401100134)
14. Sjövall J. Analysis of steroids by liquid-gel chromatography and computerized gas chromatography-mass spectrometry. Journal of Steroid Biochemistry 1975 6 227-232.
15. Arlt W, Biehl M, Taylor AE, Hahner S, Libe R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. Journal of Clinical Endocrinology and Metabolism 2011 96 3775-3784. (doi:10.1210/jc.2011-1565)
16. Honour J. Development and validation of a quantitative assay based on tandem mass spectrometry. Annals of Clinical Biochemistry 2011 48 97-111. (doi:10.1258/acb.2010.010176)
17. Yates AM, Bowron A, Calton L, Heynes J, Field H, Rainbow S & Keevil B. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxy-vitamin D3 is significantly improved if common calibration material is used. Clinical Chemistry 2008 54 2082-2084. (doi:10.1373/clinchem. 2008.110452)
18. Middle JG. Dehydroepiandrosterone sulphate interferes in many direct-infusion immunoassays for testosterone. Annals of Clinical Biochemistry 2007 44 173-177. (doi:10.1258/000456307780118082)
19. Guo T, Taylor RL, Singh RJ & Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chormatography-photospray ionization tandem mass spectrometry. Clinica Chimica Acta 2006 372 76-82. (doi:10.1016/j.cca.2006.03.034)
20. Scwartz E, Liu A, Randall H, Keune F, Murray M, Longo N & Pasquali M. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience. Pediatric Research 2009 66 230-235. (doi:10.1203/PDR.0b013e3181aa3777)
21. Hicks R, Yee JK, Mao CS, Graham S, Kharrazi M, Lorey F & Lee WP. Precursor to product ratios reflect biochemical phenotype in congenital adrenal hyperplasia. Metabolomics 2014 10 123-131. (doi:10.1007/s11306-013-0558-1)
22. Peitzsch M, Dekkers T, Haase M, Sweep FC, Quack I, Antoch G, Siegert G, Lenders JW, Deinum J, Willenberg HS & Eisenhofer G. An LC-MS/MS method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism. Journal of Steroid Biochemistry and Molecular Biology 2015 14 75-84. (doi:10.1016/j.jsbmb.2014.10.006)
23. O'Reilly M, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, Stewart PM, Tomlinson JW & Arlt W. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. Journal of Clinical Endocrinology and Metabolism 2014 99 1027-1036. (doi:10.1210/jc.2013-3399)
24. Münzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E et al. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2015 100 653-660. (doi:10.1210/jc.2014-2523)
25. Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG & Darby D. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11b-hydroxylase inhibitor metyrapone. Annals of Clinical Biochemistry 2011 48 441-446. (doi:10.1258/acb.2011.011014)
26. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, Czajko RJ &Inder WJ. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. Journal of Clinical Endocrinology and Metabolism 2011 96 1533-1540. (doi:10.1210/jc.2010-2395)
27. Owen LJ, Adaway JE, Davies S, Neale S, El-Farhan N, Ducroq D, Evans C, Rees DA, MacKenzie F & Keevil BG. Development of a rapid assay for the analysis of serum cortisol and its implementation into a routine service laboratory. Annals of Clinical Biochemistry 2013 50 345-352. (doi:10.1177/0004563212473448)
28. Taylor RL, Grebe SK & Singh RJ. Quantitative highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clinical Chemistry 2004 50 2345-2352. (doi:10.1373/clinchem.2004.033605)
29. Perogamvros B, Keevil BG, Ray DW & Trainer PJ. Salivary cortisone is a potential biomarker for serum free cortisol. Journal of Clinical Endocrinology and Metabolism 2010 95 4951-4958. (doi:10.1210/jc.2010-1215)
30. Raff H. Cushing sydrome: update on testing. Endocrinology and Metabolism Clinics of North America 2015 44 43-50. (doi:10.1016/j.ecl.2014.10.005)
31. Hershel R & Singh RJ. Measurement of late-night salivary cortisol and cortisone by LC-MS/MS to assess preanalytical sample contamination with topical hydrocortisone. Clinical Chemistry 2012 58 947-948. (doi:10.1373/clinchem.2012.182717)
32. Middle JG & Kane JW. Oestradiol assays: fitness for purpose? Annals of Clinical Biochemistry 2009 46 441-456. (doi:10.1258/acb.2009.009102)
33. Fiers T, Casetta B, Bernaert B, Vandersypt E, Debock M & Kaufman J-M. Development of a highly sensitive method for the quantification of oestrone and oestradiol in serum without derivatisation. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2012 15 893-894. (doi:10.1016/j.jchromb.2012.02.034)
34. Owen LJ, Wu FC & Keevil BG. A rapid direct assay for the routine measurement of oestradiol and oestrone by liquid chromatography- tandem mass spectrometry without derivatisation. Annals of Clinical Biochemistry 2014 51 360-367. (doi:10.1177/0004563213501478)
35. Rosner W, Hankinson SE, Sluss PM, Vesper HW & Wierman ME. Challenges to the measurement of estradiol: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2013 98 1376-1387. (doi:10.1210/jc.2012-3780)
36. Carter GD. 25-hydroxyvitamin D: a difficult analyte. Clinical Chemistry 2012 58 486-488. (doi:10.1373/clinchem.2011.180562)
37. Coldwell RD, Trafford DJ, Makin HL, Varely MJ & Kirk DN. Specific estimation of 24,25-dihydroxyvitaminD in plasma by gas chromatography-mass spectrometry. Clinical Chemistry 1984 30 1193-1198.
38. Heijboe AC, Blankenstein MA, Kema IP & Bujis MM. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clinical Chemistry 2012 58 543-548. (doi:10.1373/clinchem.2011.176545)
39. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P & Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clinical Chemistry 2012 58 531-543. (doi:10.1373/clinchem.2011.172155)
40. Notice of vitamin D standardization program. Federal Register 2011 7611502.
41. Yalow RS & Berson SA. Assay of plasma insulin in human subjects by immunological methods. Nature 1959 184 (Suppl 21) 1648-1649. (doi:10.1038/1841648b0)
42. Abraham GE. Solid-phase radioimmunoassay of estradiol-17b. Journal of Clinical Endocrinology and Metabolism 1969 29 866-870. (doi:10.1210/jcem-29-6-866)
43. Letter of concern. Journal of Clinical Endocrinology and Metabolism 2014 99 1499. (doi:10.1210/jc.2014-1873)
44. Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM & Stanczyk FZ. Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Journal of Clinical Endocrinology and Metabolism 2014 28 1917. (doi:10.1007/s12672-014-0202-1)
45. Vesper HW, Bhasin S, Wang C, Tai SS, Dodge LA, Singh RJ, Nelson J, Ohorodnik S, Clarke NJ, Salameh WA et al. Interlaboratory comparison study of serum testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 2009 74 498-503. (doi:10.1016/j.steroids.2009.01.004)
46. Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, Brzyski RG, Christman GM, Trussel JC, Krawetz SA, Snyder PJ et al. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. Journal of Clinical Endocrinology and Metabolism 2010 95 5305-5313. (doi:10.1210/jc.2010-1123)
47. Vesper HW, Botelho JC, Vidal ML, Rahmani Y, Thienport LM &Caudill SP. High variability in serum estradiol measurements in men and women. Steroids 2014 82 7-13. (doi:10.1016/j.steroids.2013.12.005)
48. Wood L, Ducroq DH, Fraser HL, Gillingwater S, Evans C, Pickett AJ, Rees DW, John R & Turkes A. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Annals of Clinical Biochemistry 2008 45 380-388. (doi:10.1258/acb.2007.007119)
49. Dodd AJ, Ducroq D, Neale SM, Wise MP, Mitchem KL, Armston A, Barth JH, El-Farhan N, Rees DA & Evans C. The effect of serum matrix and gender on cortisol measurements by commonly used immunoassays. Annals of Clinical Biochemistry 2014 51 379-385. (doi:10.1177/0004563213514567)
50. Turpeinene U & Hamalainen E. Determination of cortisol in serum, saliva and urine. Best Practice & Research. Clinical Endocrinology &Metabolism 2013 27 795-801. (doi:10.1016/j.beem.2013.10.008)
51. El-Farhan N, Pickett AJ, Ducroq D, Bailey C, Mitchem K, Morgan N, Armston A, Jones L, Evans C & Rees DA. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clinical Endocrinology 2013 78 673-680. (doi:10.1111/cen.12039)
52. Miller R, Plessow F, Rauh M, Gröschl M & Kirschbaum C. Comparison of salivary cortisol as measured by different immunoassays and tandem mass spectrometry. Psychoneuroendocrinology 2013 38 50-57. (doi:10.1016/j.psyneuen.2012.04.019)
53. Briegel J, Sprung CL, Annane D, Singer M, Keh D, Moreno R, Möhnle P, Weiss Y, Avidan A, Brunkhorst FM et al. Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Medicine 2009 35 2151-2156. (doi:10.1007/s00134-009-1627-9)
54. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 2007 92 405-413. (doi:10.1210/jc.2006-1864)
55. Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS et al. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. European Journal of Endocrinology/European Federation of Endocrine Societies 2012 166 983-991. (doi:10.1530/EJE-11-1051)
56. Chen Y, Kinney L & Soldin SJ. Performance evaluation of Siemens ADVIA Centaur enhanced estradiol assay and a split sample comparison with liquid chromatography-tandem mass spectrometry. Clinical Biochemistry 2012 45 811-815. (doi:10.1016/j.clinbiochem.2012.02.016)
57. Hsing AW, Stanczyk FZ, Bélanger A, Schroeder P, Chang L, Falk RT &Fears TR. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiology, Biomarkers & Prevention 2007 16 1004-1008. (doi:10.1158/1055-9965.EPI-06-0792)
58. Norjavaara E, Ankarberg C & Albertsson-Wikland K. Diurnal rhythm of 17b-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay. Journal of Clinical Endocrinology and Metabolism 1996 81 4095-4102.
59. Klein KO, Baron J, Colli MJ, McDonnell DP & Cutler GB Jr. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. Journal of Clinical Investigation 1994 94 2475-2480. (doi:10.1172/JCI117616)
60. Khosla S, Amin S, Singh RJ, Atkinson EJ, Melton LJ III & Riggs BL. Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporosis International 2008 19 1465-1471. (doi:10.1007/s00198-008-0591-5)
61. Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS & Endocrine Society . Osteoporosis in men: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2012 97 1802-1822. (doi:10.1210/jc.2011-3045)
62. Callou de Sá EQ, Feijó de Sá FC, e Silva Rde S, de Oliveira KC, Guedes AD, Feres F & Verreschi IT. Endogenous oestradiol but not testosterone is related to coronary artery disease in men. Clinical Endocrinology 2011 75 177-183. (doi:10.1111/j.1365-2265.2011.04017.x)
63. Jeon GH, Kim SH, Yun SC, Chae HD, Kim CH & Kang BM. Association between serum estradiol level and coronary artery calcification in postmenopausal women. Menopause 2010 17 902-907. (doi:10.1097/gme.0b013e3181d76768)
64. Chen Y, Zeleniuch-Jacquotte A, Arslan AA, Wojcik O, Toniolo P, Shore RE, Levitz M & Koenig KL. Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis 2011 216 414-419. (doi:10.1016/j.atherosclerosis.2011.01.053)
65. Ahmed B, Bairey Merz CN, Johnson BD, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Smith K, Shaw L, Kelsey SF et al. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). American Journal of Cardiology 2008 102 150-154. (doi:10.1016/j.amjcard.2008.03.029)
66. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N & Hollis BW. 25-hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. American Journal of Clinical Nutrition 2008 87 1738-1742.
67. Granado Lorencio F, Blanco-Navarro I & Pérez-Sacrsitán B. Critical evaluation of assays for vitamin D status. Current Opinion in Clinical Nutrition and Metabolic Care 2013 16 734-740. (doi:10.1097/MCO.0b013e328364ca96)
68. Farrell CJ & Herrmann M. Determination of vitamin D and its metabolites. Best Practice & Research. Clinical Endocrinology & Metabolism 2013 27 675-688. (doi:10.1016/j.beem.2013.06.001)
69. Chen H, McCoy LF, Schleicher RL & Pfeiffer CM. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clinica Chimica Acta 2008 391 6-12. (doi:10.1016/j.cca.2008.01.017)
70. Koivula MK, Turpeinen U, Laitinen P & Risteli J. Comparison of automated 25-OH vitamin D immunoassays with liquid chromatography isotope dilution tandem mass spectrometry. Clinical Laboratory 2012 58 1253-1261.
71. Shin SY, Kwon MJ, Song J, Park H & Woo HY. Measurement of serum total vitamin D (25-OH) using automated immunoassay in comparison [corrected] with liquid chromatography tandem-mass spectrometry. Journal of Clinical Laboratory Analysis 2013 27 284-289. (doi:10.1002/jcla.21598)
72. Caillet P & Schott AM. Vitamin D testing-author reply. Lancet 2012 379 5-11. (doi:10.1016/S0140-6736(12)60710-7)